Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

NCT00002989 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

207

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

DRUG: busulfan
DRUG: cyclophosphamide
DRUG: idarubicin
DRUG: melphalan
RADIATION: radiation therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC